Economic evaluations of pharmacist‐managed services in people with diabetes mellitus: a systematic review

Wang, Y.; Yeo, Qui; Ko, Yu

doi:10.1111/dme.12976

Cited by 62 publications

(61 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Diabetes, a metabolic disorder with rapid emerging epidemic, accounts for a total of 387 million global population living with diabetes till 2014 (1). It is associated with substantial indisposition toward other illnesses and a major risk factor for cardiovascular disease, stroke, and renal complications (1).…”

Section: Introductionmentioning

confidence: 99%

“…It is associated with substantial indisposition toward other illnesses and a major risk factor for cardiovascular disease, stroke, and renal complications (1). According to the National Health and Morbidity Survey (NHMS) 2011, “the prevalence of diabetes in Malaysia had amplified relatively from 15.2% (2011) to current 17.5%, compared to the relative increase of 31.0% between 2006 (prevalence: 11.6%) and 2011” (2).…”

Section: Introductionmentioning

confidence: 99%

“…Diabetes cases also increase sequentially with age and are at its peak in the age group of 70–74 years (2). The intensifying drift in diabetes is distressing because the disease generates undesirable impacts on patients, their families and caregivers and society, both humanistically and financially owing to significant cost involved in diabetes care (1). …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Evaluation of the Involvement of Pharmacists in Diabetes Self-Care: A Review From the Economic Perspective

Jamshed

Siddiqui

Rana

et al. 2018

Front. Public Health

View full text Add to dashboard Cite

Objectives: To analyze the studies encompassing the involvement of pharmacists in diabetes self-care.Method: We reviewed studies conducted from 2005 to 2017 on the involvement of pharmacists in diabetes self-care. The keywords mainly used in this search are pharmacoeconomic analysis, diabetes self-care, pharmacist involvement,cost-effectiveness analysis, cost of utilization, cost of illness, cost of minimization and cost-benefit analysis. PubMed, Science Direct, Springer Link and Medline searched for the relevant studies. These databases searched for full text articles ranging from 2007 to 2017. We tried to limit the search with the inclusion of studies having any sort of pharmacoeconomically relevant component.Key Findings: Cost of illness varied among the countries in managing diabetes mellitus, and the cost of managing diabetes complications were twice the cost of management of diabetes. Continuous involvement of the pharmacist in primary health care is a cost-effective strategy and pronounced to be essential for helping diabetes patient in controlling and managing their disease. Implementation of diabetes self-care by pharmacists such as lifestyle intervention rendered improved quality of life of patient without any increase in health care cost. Self-care management generates intensive blood glucose control and improved quality of life.Conclusions: Implementation of diabetic self-care intervention including intensive lifestyle intervention, education, self-monitoring of blood glucose and adherence toward medication-initiated reduction in the overall healthcare cost of diabetic patients compared to patients relying on only any one of the interventions. Impact of diabetes self-care intervention by pharmacist reported to significantly reduce the HbA1C levels of diabetic patients along with the reduction of yearly healthcare cost. This review showed that pharmacist involvement in diabetes self-care interventions prove to be cost-effective and can significantly affect the condition of the diabetic patients and reduces the risk of complications.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of the Involvement of Pharmacists in Diabetes Self-Care: A Review From the Economic Perspective

Jamshed

Siddiqui

Rana

et al. 2018

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…Pharmacists are capable of providing a wide range of services that can reduce health care costs, such as proper drug counseling, selfmanagement support, drug-related problem identification, effective patient education, and training on blood glucose and blood pressure monitoring. [19][20][21][22][23][24] The role of pharmacists in patient care was extensively investigated by Rotta et al 25 A systematic review of 269 randomized controlled trials on pharmacist-delivered patient care clearly demonstrated that clinical services offered by pharmacists positively impact health-related outcomes. In addition, the role of the pharmacists' clinical services in chronic disease management was clearly demonstrated in 1996 in the Asheville project.…”

mentioning

confidence: 99%

A qualitative assessment of West Virginia pharmacist activities and attitude in diabetes management

Shatnawi

Latif

2016

Evaluation Clinical Practice

View full text Add to dashboard Cite

show abstract

“…Multiple studies have demonstrated that when pharmacists are added to the health care team in providing diabetes management, an improvement in glycosylated hemoglobin (A1C) is seen. 16,17 An important component of patient-centered care is shared decision-making characterized by effective patient-provider communication, where patients weigh treatment choices in light of the potential benefit and harm and arrive at informed preferences. 4,[9][10][11][12][13][14][15] Incorporating clinical pharmacists into the care team has demonstrated cost savings and improved quality-adjusted life years.…”

Section: Introductionmentioning

confidence: 99%

Family physician perceptions of the role and value of the clinical pharmacist in the management of patients with type 2 diabetes

Harmes

Shih

Plegue

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Purpose Clinical pharmacists can help primary care physicians (PCPs) manage medications for patients with poorly controlled type 2 diabetes. Studies have shown that clinical pharmacist involvement in care can improve outcomes such as glycosylated hemoglobin (A1C), blood pressure and lipid control, and decrease episodes of hypoglycemia. Despite these findings, some PCPs may be slow or disinclined to refer to clinical pharmacists when available. This study addressed PCP perceptions regarding referral to clinical pharmacists and endocrinologists for patients with poorly controlled type 2 diabetes. Methods Physicians from five family medicine sites were surveyed. Physicians were queried regarding their patterns for patient referral to endocrinologists and/or clinical pharmacists. Clinical contributions and importance of factors to consider when referring were compared between clinical pharmacists and endocrinologists using paired t tests. Results Fifty physicians responded to the survey, resulting in a response rate of 73.5%. The majority of PCPs indicated that they have referred to endocrinologists (89.5%) and clinical pharmacists (93.5%) for specialty care. PCPs tended to refer to clinical pharmacists sooner and at lower A1C values than to endocrinologists. PCPs also considered multiple medical comorbidities, history of noncompliance with medical recommendations, low reading ability or math skills, complex psychosocial situations, fear of needles, or difficulty affording medications or supplies to be more important when referring patients to clinical pharmacists than endocrinologists. Conclusion We hypothesized that referrals to a clinical pharmacist or endocrinologist are made with careful consideration of the patients' needs. PCPs reported increased utilization of clinical pharmacists for patients with nonmedical needs, indicating that extra time, education, and psychosocial support provided by the clinical pharmacist is highly valued.

show abstract

Economic evaluations of pharmacist‐managed services in people with diabetes mellitus: a systematic review

Cited by 62 publications

References 29 publications

Evaluation of the Involvement of Pharmacists in Diabetes Self-Care: A Review From the Economic Perspective

Evaluation of the Involvement of Pharmacists in Diabetes Self-Care: A Review From the Economic Perspective

A qualitative assessment of West Virginia pharmacist activities and attitude in diabetes management

Family physician perceptions of the role and value of the clinical pharmacist in the management of patients with type 2 diabetes

Contact Info

Product

Resources

About